Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Wound Care 3rd Edition Vol III Surgical and Trauma Wounds

Wound Care 3rd Edition Vol III Surgical and Trauma Wounds

There are millions of surgical procedures performed annually worldwide and the market for wound care products and techniques is significant. In the United States alone, there are over 100,000 surgeries performed daily. Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area. Enjoying market success depends on several factors. Manufacturers must develop a formidable strategy, which involves matching internal capabilities with external opportunities. By choosing to implement such strategies, providers are able to achieve high levels of clinical success while controlling use and costs. Manufacturers are continuing to create well-rounded and advanced products to provide a wider variety of choices. The aging of the population and continued advances in biotechnology drive the wound care industry. The aging world population created increased demand for all types of surgical intervention, particularly cardiovascular, orthopedic, urological and dermatological procedures. The emerging generation of wound care products and technologies are well-positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.

Wound Care, 3rd. Edition, Vol. III: Surgical and Trauma Wounds details total manufacturers’ revenues from the following product categories:

Wound Closure

Sutures

Staples

Tissue adhesives, sealants and glues

Anti-infectives

Surgical and trauma wound management

Wound cleaners

Debridement

Tapes

Dry dressings

Moist Dressings

Alginates

Films

Foams

Hydrocolloids

Hydrogels

Biological Dressings

Artificial Skin

Collagen

Growth Factors

Miscellaneous Treatments

The information and analysis presented in this report are based on an extensive survey of senior management in the prescription women’s health drug industry. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the women’s health industry.

Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections. All market data pertains to the U.S. market at the manufacturers’ level. Revenues in the report are based on sales at the manufacturers’ level for the following markets:

Wound Closure

Anti-infectives

Surgical and Trauma Wound Management

Moist Dressings

Biological Dressings

Miscellaneous Surgical Wound and Trauma Treatments

The market is varied in terms of both product offerings and product maturity. Several of the segments are mature such as anti-infectives, wound management, and sutures and staples of the wound closure market, while others such as biological dressings, some moist dressings, and sealants, adhesives, and glues of the wound closure segment are in the infant stages of development.

Thus some segments within the market are slowing in growth rates while others are driving growth. As identified in the report, conventional, mature products continue to generate the majority of sales; however, their growth rate is slow and limited by the maturity of the product and the competition. Advancements in technology are expected to drive growth during the forecast period.

Product Managers, Marketing Directors in the wound care industry as well as financial and consulting executives are among those that will find this a useful resource.

Published: Sept, 1 2007

Pages: 219

PDF Format
Table of Contents
Sample Pages
Price: $2,995.00 / €2,003.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions